Terms: = Thyroid cancer AND ERC1, ELKS, 23085, ENSG00000082805, MGC12974, RAB6IP2, KIAA1081, Cast2, Q8IUD2, KIAA108
13 results:
1. Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing.
Shi M; Wang W; Zhang J; Li B; Lv D; Wang D; Wang S; Cheng D; Ma T
Cancer Sci; 2022 Jan; 113(1):308-318. PubMed ID: 34710947
[TBL] [Abstract] [Full Text] [Related]
2. thyroid nodules in childhood-onset Hashimoto's thyroiditis: Frequency, risk factors, follow-up course and genetic alterations of thyroid cancer.
Lee YJ; Cho YJ; Heo YJ; Chung EJ; Choi YH; Kim JI; Park YJ; Shin CH; Lee YA
Clin Endocrinol (Oxf); 2021 Oct; 95(4):638-648. PubMed ID: 33894068
[TBL] [Abstract] [Full Text] [Related]
3. Pitfalls in RET Fusion Detection Using Break-Apart FISH Probes in Papillary thyroid Carcinoma.
Liu Y; Wu S; Zhou L; Guo Y; Zeng X
J Clin Endocrinol Metab; 2021 Mar; 106(4):1129-1138. PubMed ID: 33382428
[TBL] [Abstract] [Full Text] [Related]
4. Detection of NTRK1/3 Rearrangements in Papillary thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
Lee YC; Chen JY; Huang CJ; Chen HS; Yang AH; Hang JF
Endocr Pathol; 2020 Dec; 31(4):348-358. PubMed ID: 32880785
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
[TBL] [Abstract] [Full Text] [Related]
6. [Oncogenes RET/PTC and mechanisms of their involvement in thyroid cancerogenesis].
Voskoboĭnyk LH
Ukr Biokhim Zh (1999); 2009; 81(6):17-25. PubMed ID: 20387655
[TBL] [Abstract] [Full Text] [Related]
7. Papillary carcinoma of the breast lacks evidence of RET rearrangements despite morphological similarities to papillary thyroid carcinoma.
Hameed O; Perry A; Banerjee R; Zhu X; Pfeifer JD
Mod Pathol; 2009 Sep; 22(9):1236-42. PubMed ID: 19543246
[TBL] [Abstract] [Full Text] [Related]
8. [Gene rearrangement analysis of papillary thyroid carcinoma].
Wang YL; Wang JC; Li DS; Zhu YX; Wu Y; Ji QH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 42(12):929-33. PubMed ID: 18335752
[TBL] [Abstract] [Full Text] [Related]
9. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and elks-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.
Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT
Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154
[TBL] [Abstract] [Full Text] [Related]
10. The RET proto-oncogene: a molecular therapeutic target in thyroid cancer.
Kodama Y; Asai N; Kawai K; Jijiwa M; Murakumo Y; Ichihara M; Takahashi M
Cancer Sci; 2005 Mar; 96(3):143-8. PubMed ID: 15771616
[TBL] [Abstract] [Full Text] [Related]
11. Differential expression of multiple isoforms of the elks mRNAs involved in a papillary thyroid carcinoma.
Nakata T; Yokota T; Emi M; Minami S
Genes Chromosomes Cancer; 2002 Sep; 35(1):30-7. PubMed ID: 12203787
[TBL] [Abstract] [Full Text] [Related]
12. Genomic organization and chromosomal mapping of elks, a gene rearranged in a papillary thyroid carcinoma.
Yokota T; Nakata T; Minami S; Inazawa J; Emi M
J Hum Genet; 2000; 45(1):6-11. PubMed ID: 10697956
[TBL] [Abstract] [Full Text] [Related]
13. Fusion of a novel gene, elks, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma.
Nakata T; Kitamura Y; Shimizu K; Tanaka S; Fujimori M; Yokoyama S; Ito K; Emi M
Genes Chromosomes Cancer; 1999 Jun; 25(2):97-103. PubMed ID: 10337992
[TBL] [Abstract] [Full Text] [Related]
